Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

✍ Scribed by Mittendorf, E. A.; Clifton, G. T.; Holmes, J. P.; Schneble, E.; van Echo, D.; Ponniah, S.; Peoples, G. E.

• Book ID: 125442185
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 277 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdu211